Physician profile
David K Smith
NPI 1609834068
$781.06
in general payments reported to CMS, 2019-2025
20 companies · $80.56 in 2025
The $80.56 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $112 · 2021: $53.09 · 2022: $27.19 · 2023: $87.91 · 2024: $115 · 2025: $80.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $147.53 | 2023-2025 | Veozah |
| Allergan, INC. | $92.99 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $56.54 | 2019-2020 | |
| Lupin INC. | $53.01 | 2019-2020 | |
| Therapeuticsmd, INC. | $50.73 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $50.41 | 2022-2024 | |
| Abbott Laboratories | $40.79 | 2019 | |
| Daiichi Sankyo INC. | $39.42 | 2019 | |
| Exact Sciences Corporation | $35.24 | 2023 | Cologuard Collection Kit |
| Abbvie INC. | $30.66 | 2019 | |
| Millicent US INC | $29.45 | 2024-2025 | Femring, Intrarosa |
| Amag Pharmaceuticals, INC. | $26.91 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.46 | 2019 | |
| Sanara Medtech INC. | $17.24 | 2025 | Celleraterx |
| Duchesnay USA Incorporated | $16.86 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.53 | 2021 | |
| Currax Pharmaceuticals LLC | $15.77 | 2023 | Contrave |
| Hologic Sales and Service, LLC | $15.26 | 2019 | |
| Organon LLC | $14.78 | 2025 | Nexplanon |
| Avion Pharmaceuticals | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.